Indivior Plc on Monday said a U.S. Court granted-in-part a motion to expedite a rival's appeal of a preliminary injunction that blocked the sale of copycat versions of the British drugmaker's bestselling opioid addiction treatment in the United States.
from Reuters: Company News https://ift.tt/2OrdzXL
via IFTTT
0 comments:
Post a Comment